TwinBeech Capital’s NeoGenomics NEO Stock Holding History

TwinBeech Capital’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-106,300	Closed	-$789K	–	582
2026 Q1	$789K	Buy	+106,300	New	+$1.12M	0.08%	299
2025 Q3	–	Sell	-32,354	Closed	-$237K	–	745
2025 Q2	$237K	Buy	+32,354	New	+$261K	0.01%	576
2024 Q3	–	Sell	-36,708	Closed	-$509K	–	817
2024 Q2	$509K	Buy	+36,708	New	+$520K	0.01%	452
2023 Q4	–	Sell	-166,414	Closed	-$2.05M	–	822
2023 Q3	$2.05M	Buy	166,414 +143,359	+622%	+$2.13M	0.04%	408
2023 Q2	$370K	Buy	+23,055	New	+$380K	0.01%	526
2022 Q4	–	Sell	-59,689	Closed	-$514K	–	853
2022 Q3	$514K	Buy	+59,689	New	+$593K	0.01%	522
2022 Q2	–	Sell	-161,737	Closed	-$1.97M	–	651
2022 Q1	$1.97M	Buy	+161,737	New	+$3.4M	0.09%	245

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

TwinBeech Capital's NEO Position: Q2 2026 in Review

TwinBeech Capital sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 106,300 shares — an estimated $789K sold.

TwinBeech Capital first reported a position in NEO in Q1 2022 and held it in 7 quarters. The position peaked at $2.05M in Q3 2023. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

TwinBeech Capital reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
TwinBeech Capital sold 106,300 NeoGenomics shares in Q2 2026, an estimated $789K.
TwinBeech Capital first reported a position in NeoGenomics in Q1 2022 and held it in 7 quarters.
TwinBeech Capital's NeoGenomics position peaked at $2.05M in Q3 2023.
266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.